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Introduction
New food introduced to an inflamed gut may result in
sensitization to this food. AIM Evaluate the time required
for recovery after chronic inflammatory intestinal process
for the development of oral tolerance to new proteins.
Methods and results
Male C57BL/6 mice (n=30) were immunized with 100μg
of peanut protein. Half received a 30-day raw-peanut-
challenge-diet (CD) (inflamed-I) while the other received
mouse chow (controls-C)(Teixeira 2008). They were
further divided and received sweetened OVA (new pro-
tein) (egg white diluted in distilled H2O, 1:5 v/v+5%
sucralose) orally for 7 days, on day 0 (I1 C1), 10 (I2 C2)
or 20 (I3 C3) post CD. We assessed body weight, food
intake, antibodies and T cell phenotype of mesenteric
lymph nodes (MLN) and spleen (SPN). ANOVA with
Tukey post-test was performed. Statistical significance
considered p<0.05. This study was approved by UFF’s
Ethical Committee (CEUA #00147-09). During CD
groups I2 (-1.94±2.2) and I3 (-1.44±1.8) but not I1 (0.15
±0.6) showed significant weight loss compared to C. The
C groups (37.50±4.6) ingested significantly more kcals
compared to I1 (31.20±2.6), I2 (30.78±2.5) and I3 (30.84
±3.4). OVA consumption was significantly lower in I1
(3.21±1.0) compared to I2 (6.53±1.19), I3 (6.82±2.3) and
C (7.5±1.7). In the MLN we observed a significant
increase of CD8+T cells of I1 (29.49±4.1) and I2 (31.72
±4.0) compared to I3 (21.53±3.6) and C (25.65±5.4) and
CD8+CD25+T I1 (0.43±0.2) when compared to I2 (0.32
±0.0), I3 (0.24±0.1) and C (0.30±0.1) with no significant
difference in CD4+T cells (I 37.34±5.7 and C 38.35±5.1)
and CD4+CD25+ T cells (I 6.86±1.5 and C 7.00±1.9). In
SPN, we observed significantly increase of CD4+T cells
in I1 (38.67±2.5) compared to I2 (25.93±3.48), I3
(24.48±5.9) and C (26.25±12.2) which was not accom-
panied by the increase of CD4+CD25+Foxp3+T cells.
We observed a significant increase in the CD8+CD25+
T cells in I1 (0.25±0.1) compared to I2 (0.11±0.0), I3
(0.1+0.0) and C (0.1±0.1). The I-1 showed gut inflam-
mation, increased intraepithelial leukocytes and
destruction/flatning of the villi and drop of goblet
cells. The I-2 and 3 were similar to C.
Conclusions
Aversion to novel proteins by animals with gut inflam-
mation may be a protective mechanism to the induction
of multiple allergies.
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